MRSN: Mersana Therapeutics, Inc. Stock

by  •  • Comments Off on MRSN: Mersana Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 37.84
Enterprise Value ($M) -46.46
Book Value ($M) -9.51
Book Value / Share -0.08
Price / Book -3.98
NCAV ($M) -17.27
NCAV / Share -0.14
Price / NCAV -2.19

Profitability (mra)
Return on Invested Capital (ROIC) -3.61
Return on Assets (ROA) -0.35
Return on Equity (ROE) -2.47

Liquidity (mrq)
Quick Ratio 2.19
Current Ratio 2.19

Balance Sheet (mrq) ($M)
Current Assets 136.90
Assets 144.66
Liabilities 154.17
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 40.50
Operating Income -73.34
Net Income -69.19
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -82.34
Cash from Investing 11.44
Cash from Financing 4.09

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 8.30 -9.45
02-05 13G/A BlackRock, Inc. 8.00 17.35
12-26 13G/A Nextech Crossover I GP S.a r.l. 10.40 0.00
12-23 13G/A EcoR1 Capital, LLC 9.99 -40.21
11-15 13D/A Bain Capital Life Sciences Fund II, L.P. 4.00 22.92
11-14 13G/A Balyasny Asset Management Llc 0.44 -94.48
10-15 13G/A Silverarc Capital Management, Llc 1.43 -72.68

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-10 1,342,712 3,655,895 36.73
2025-04-09 683,595 2,504,890 27.29
2025-04-08 577,428 1,666,490 34.65
2025-04-07 1,102,369 3,348,483 32.92

(click for more detail)

Similar Companies
MLYS – Mineralys Therapeutics, Inc. MNMD – Mind Medicine (MindMed) Inc.
MRNA – Moderna, Inc. MRVI – Maravai LifeSciences Holdings, Inc.
MYGN – Myriad Genetics, Inc.


Financial data and stock pages provided by
Fintel.io